[Methotrexate as an adjuvant in radiotherapy of squamous cell carcinoma of the throat nose-ear-area].
D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000532:radiotherapy*; D004428:Ear Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage* / Q000633:toxicity; D009362:Neoplasm Metastasis / Q000628:therapy; D009364:Neoplasm Recurrence, Local / Q000628:therapy; D009669:Nose Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D010610:Pharyngeal Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D011446:Prospective Studies; D013997:Time Factors
D008727:Methotrexate
Methotrexat als Adjuvans zur Strahlentherapie bei Plattenepithelkarzinomen im Hals-Nasen-Ohren Bereich.